Difesa Capital Management’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding EQHA.WS
Difesa Capital Management's EQHA.WS Position: Q4 2022 in Review
Difesa Capital Management sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 37,500 shares — an estimated $3K sold.
Difesa Capital Management first reported a position in EQHA.WS in Q4 2021 and held it in 4 quarters. The position peaked at $20K in Q4 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.
- Difesa Capital Management reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
- Difesa Capital Management sold 37,500 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $3K.
- Difesa Capital Management first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 4 quarters.
- Difesa Capital Management's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $20K in Q4 2021.
- 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.
Based on Difesa Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.